As MSI‐H status is often associated with hypermethylation induced MLH1 inactivation and BRAF mutation,20 we also studied whether these molecular events contributed to a poorer prognosis in GC patients with MSI‐H. This evidence concerns the gene MLH1 and gastric cancer.